Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ATM | Q13315 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24090554 | 0.90 | ATM (0.37) | ATM | |
| SCHEMBL24090553 | 0.82 | — | — | |
| SCHEMBL19513185 | 0.82 | — | — | |
| SCHEMBL24090573 | 0.76 | ATM (0.35) | ATM | |
| SCHEMBL19513184 | 0.74 | HSD11B1 (0.39) | — | |
| SCHEMBL13686060 | 0.72 | — | — | |
| SCHEMBL19498047 | 0.72 | ATM (0.35) | ATM | |
| SCHEMBL15889404 | 0.72 | ATM (0.35) | ATM | |
| SCHEMBL9883800 | 0.72 | ATM (0.35) | ATM | |
| SCHEMBL22387268 | 0.69 | ATM (0.37) | ATM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3868763-B1 | COMPOUND AND METHOD FOR PRODUCING SAME | UNIV OSAKA (JP) | 2024-07-03 | — | — | EP | disclosed |
| US-20210380594-A1 | COMPOUND, AND METHOD FOR PRODUCING THE SAME | N.E. CHEMCAT CORPORATION (JP) | 2021-12-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210380594-A1 | COMPOUND, AND METHOD FOR PRODUCING THE SAME | POR, CYP19A1, CYP1A1 | ATM 1738/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.